Furthermore, while COX-2 overexpression is effective in inducing mammary gland tumorigenesis, treatment with COX-2 inhibitors or gene ablation may reduce experimentally induced breast cancers [44], [46], [47]. Here, PTGS2 is linked to breast carcinoma.